GlobeNewswire
Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects
📈
AI Sentiment
Highly Positive
9/10
Novartis AG News
Latest updates and market news for NVS
3 news
Jan 2 - Jan 8, 2026
Page 1
Zacks
Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China
📉
AI Sentiment
Negative
3/10
Share this news page